Key Takeaways Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies.A jury in October found the ...
The decision to allow a new trial could have implications for both the companies and families with babies born prematurely.
Zacks Investment Research on MSN7h
Abbott (ABT) Stock Moves -0.23%: What You Should Know
The most recent trading session ended with Abbott (ABT) standing at $131.63, reflecting a -0.23% shift from the previouse trading day's closing. The stock outperformed the S&P 500, which registered a ...
Abbott was down 2.7% at 1:54 p.m. in New York after paring morning losses, while Reckitt’s shares fell as much as 5.6% in London before closing down 1.7%. Both early declines were the biggest in ...
Exclusive new testing by Consumer Reports highlights safer formulas while also identifying some that contain potentially ...
Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in ...
Motherly on MSN13d
The government is ramping up baby formula safety testing and supply
The government launches Operation Stork Speed to improve baby formula safety, transparency, and supply. Learn what this means ...
In late October, a jury decided in favor of north suburban-based Abbott, formula maker Mead Johnson Nutrition and St. Louis Children’s Hospital, saying the three were not liable for Elizabeth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results